Difference between revisions of "Allergy & Intolerance Drug Sub-project"
| (8 intermediate revisions by the same user not shown) | |||
| Line 13: | Line 13: | ||
=Plan= | =Plan= | ||
| − | * Confirm goals | + | * Confirm goals - done |
| − | * Assess assets | + | * Assess assets - done |
| − | * Evaluate gaps | + | * Evaluate gaps - in process |
| − | * Fill gaps | + | * Fill gaps - in process |
| + | |||
| + | [[Allergy & Intolerance substance September 2017 ballot outline | Ballot outline September 2017]] | ||
=Questions= | =Questions= | ||
| Line 31: | Line 33: | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/23748627 Automated substance identification] | * [https://www.ncbi.nlm.nih.gov/pubmed/23748627 Automated substance identification] | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/17068355 CPOE & CDS] | * [https://www.ncbi.nlm.nih.gov/pubmed/17068355 CPOE & CDS] | ||
| + | * [guidance on egg content of vaccines] | ||
| + | * [[Media: Presentation_HL7_allergy_and_intolerance_drug_sub-project_-_v20170630.ppt | Dutch presentation on surveillance]] | ||
=Minutes= | =Minutes= | ||
| + | |||
| + | [[2018-04-25PC_DrugAllergySubstance_Call_Minutes | 25 April 2018]] | ||
| + | |||
| + | [[2018-04-11PC_DrugAllergySubstance_Call_Minutes | 11 April 2018]] | ||
| + | |||
| + | [[2018-03-28PC_DrugAllergySubstance_Call_Minutes | 28 March 2018]] | ||
| + | |||
| + | [[2018-03-14PC_DrugAllergySubstance_Call_Minutes | 14 March 2018]] | ||
| + | |||
| + | [[2017-06-30PC_DrugAllergySubstance_Call_Minutes | 30 June 2017 (ad hoc)]] | ||
| + | |||
| + | [[2017-06-28PC_DrugAllergySubstance_Call_Minutes | 28 June 2017]] | ||
[[May_2017_WGM_Madrid,_Spain:_May_6_to_May_12#Patient_Care_Wednesday_Q4 | 9 May 2017]] | [[May_2017_WGM_Madrid,_Spain:_May_6_to_May_12#Patient_Care_Wednesday_Q4 | 9 May 2017]] | ||
Latest revision as of 21:15, 25 April 2018
Back to Allergy & Intolerance
Contents
Purpose
Produce a list of unique substances and multiple substance medications used in allergy & intolerance lists, ordered by frequency of incidence. This list will support the use of common elements for data capture and validation of data exchange. This list is not intended to prevent the recording of unusual substances where necessary, whether by code or text.
We would like to provide a set of standard coded identifiers for these substances. The codes for such a list would need to be free, readily available, and accepted for use by international stakeholders.
Note that the criterion is clinical use, not chemical specificity. I.e., if all we know is that the patient reports an allergy to "fish," that's what we can record. Similarly, if a patient has a reaction to percocet, and the clinician doesn't have evidence that supports identification of a specific ingredient, then "percocet" is what we know.
Goal
- A list of substances ordered by frequency of incidence, with frequency ratios
- Identifiers for these substances, using freely available standard identifiers
Plan
- Confirm goals - done
- Assess assets - done
- Evaluate gaps - in process
- Fill gaps - in process
Questions
Go to Allergy & Intolerance Drug Sub-project questions
Resources
- Evaluating standard terminologies for encoding allergy information
- Food entries in a large allergy data repository
- Statin cross-reactivity
- NCPDP Recommendations
- Alert Override Results
- Rising Alert Overrides
- Automated substance identification
- CPOE & CDS
- [guidance on egg content of vaccines]
- Dutch presentation on surveillance
